Am J Clin Nutr 80(1):114122
GLP-1RAs, which are antidiabetic drugs, improve NAFLD and CVD in patients with type 2 diabetes mellitus by activating AMPK and SIRT6, key regulators of lipid, glucose, and cholesterol metabolism pathways [2326]
B., Madsbad, S., & Lund, J
If you have a personal or family history of inflammatory bowel disease, coeliac disease, or colorectal cancer, inform your prescriber, as this may influence monitoring strategies
Mounjaro (Tirzepatide) Mounjaro is a new medication that is currently undergoing approval for its use in weight loss and obesity
Research also documents upregulation of growth hormone receptor expression and signaling pathways related to cell growth, proliferation, survival, and angiogenesis